Advertisement
Person › Details
Markus Dangl (Medigene AG (FSE: MDG1, Prime Standard))
Dangl, Markus (Medigene 201603– SVP Research + Pre-Clinical Development before Roche Diagnostics GmbH)
Organisation | Medigene AG (FSE: MDG1, Prime Standard) | |
Group | Medigene (Group) | |
Former/major organisation | Roche Diagnostics GmbH | |
Group | Roche (Group) | |
Product | clinical research | |
Product 2 | cancer immunotherapy (immuno-oncology, I-O) | |
Record changed: 2018-02-20 |
Advertisement
More documents for Markus Dangl
- [1] Medigene AG. (8/30/17). "Press Release: Medigene Presents Automated Platform for TCR Identification at CAR-TCR Summit". Planegg....
- [2] Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top